S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   386.74 (-1.80%)
AAPL   164.80 (-0.30%)
MSFT   330.30 (-0.09%)
FB   311.25 (-4.07%)
GOOGL   2,828.74 (-0.32%)
AMZN   3,447.96 (-1.69%)
TSLA   1,085.50 (-5.18%)
NVDA   314.67 (-3.70%)
BABA   122.47 (-3.97%)
NIO   38.35 (-1.99%)
CGC   9.94 (-7.19%)
AMD   149.17 (-5.81%)
GE   93.23 (-1.85%)
MU   85.19 (+1.42%)
T   22.22 (-2.67%)
F   19.64 (+2.34%)
DIS   142.15 (-1.90%)
PFE   54.60 (+1.62%)
AMC   29.66 (-12.61%)
ACB   6.01 (-6.39%)
BA   187.90 (-5.03%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   386.74 (-1.80%)
AAPL   164.80 (-0.30%)
MSFT   330.30 (-0.09%)
FB   311.25 (-4.07%)
GOOGL   2,828.74 (-0.32%)
AMZN   3,447.96 (-1.69%)
TSLA   1,085.50 (-5.18%)
NVDA   314.67 (-3.70%)
BABA   122.47 (-3.97%)
NIO   38.35 (-1.99%)
CGC   9.94 (-7.19%)
AMD   149.17 (-5.81%)
GE   93.23 (-1.85%)
MU   85.19 (+1.42%)
T   22.22 (-2.67%)
F   19.64 (+2.34%)
DIS   142.15 (-1.90%)
PFE   54.60 (+1.62%)
AMC   29.66 (-12.61%)
ACB   6.01 (-6.39%)
BA   187.90 (-5.03%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   386.74 (-1.80%)
AAPL   164.80 (-0.30%)
MSFT   330.30 (-0.09%)
FB   311.25 (-4.07%)
GOOGL   2,828.74 (-0.32%)
AMZN   3,447.96 (-1.69%)
TSLA   1,085.50 (-5.18%)
NVDA   314.67 (-3.70%)
BABA   122.47 (-3.97%)
NIO   38.35 (-1.99%)
CGC   9.94 (-7.19%)
AMD   149.17 (-5.81%)
GE   93.23 (-1.85%)
MU   85.19 (+1.42%)
T   22.22 (-2.67%)
F   19.64 (+2.34%)
DIS   142.15 (-1.90%)
PFE   54.60 (+1.62%)
AMC   29.66 (-12.61%)
ACB   6.01 (-6.39%)
BA   187.90 (-5.03%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   386.74 (-1.80%)
AAPL   164.80 (-0.30%)
MSFT   330.30 (-0.09%)
FB   311.25 (-4.07%)
GOOGL   2,828.74 (-0.32%)
AMZN   3,447.96 (-1.69%)
TSLA   1,085.50 (-5.18%)
NVDA   314.67 (-3.70%)
BABA   122.47 (-3.97%)
NIO   38.35 (-1.99%)
CGC   9.94 (-7.19%)
AMD   149.17 (-5.81%)
GE   93.23 (-1.85%)
MU   85.19 (+1.42%)
T   22.22 (-2.67%)
F   19.64 (+2.34%)
DIS   142.15 (-1.90%)
PFE   54.60 (+1.62%)
AMC   29.66 (-12.61%)
ACB   6.01 (-6.39%)
BA   187.90 (-5.03%)
NASDAQ:ARQT

Arcutis Biotherapeutics SEC Filings & 10K Form

$15.49
-1.08 (-6.52%)
(As of 12/1/2021 03:59 PM ET)
Add
Compare
Today's Range
$15.49
$16.67
50-Day Range
$15.76
$25.50
52-Week Range
$15.30
$38.49
Volume
8,498 shs
Average Volume
206,083 shs
Market Capitalization
$779.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.05

Arcutis Biotherapeutics (NASDAQ:ARQT) SEC Filings

DateFilerForm TypeView
09/07/2021
6:53 PM
Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2021
6:52 PM
Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/23/2021
4:49 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4/A
07/23/2021
4:48 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4/A
07/23/2021
4:47 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4/A
07/23/2021
4:46 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4/A
07/23/2021
4:45 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4/A
07/23/2021
4:44 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4/A
07/08/2021
6:40 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
3:11 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
4:47 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:35 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
1:07 PM
Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
1:06 PM
Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2021
4:30 PM
Arcutis Biotherapeutics (Issuer)
Sun Ricky (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
3:35 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
3:39 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
3:37 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
2:10 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
5:43 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4/A
05/12/2021
5:19 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4/A
05/12/2021
4:37 PM
Arcutis Biotherapeutics (Issuer)
FHM LIFE SCIENCES VIII, L.L.C. (Reporting)
FHM LIFE SCIENCES VIII, L.P. (Reporting)
Frazier Life Sciences VIII, L.P. (Reporting)
Heron Patrick J (Reporting)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
4:27 PM
Arcutis Biotherapeutics (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
Form SC 13D/A
05/11/2021
10:47 AM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
10:29 AM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
3:12 PM
Arcutis Biotherapeutics (Filer)
Form 424B5
05/05/2021
1:05 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
4:16 PM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2021
2:00 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
3:55 PM
Arcutis Biotherapeutics (Filer)
Form DEFA14A
04/22/2021
7:17 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2021
4:43 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
4:30 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
5:50 PM
Arcutis Biotherapeutics (Issuer)
Burrows Scott L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
5:49 PM
Arcutis Biotherapeutics (Issuer)
Burrows Scott L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/05/2021
4:33 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2021
7:01 AM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2021
10:33 AM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
12:59 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
2:55 PM
Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
2:54 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
2:53 PM
Arcutis Biotherapeutics (Issuer)
Lock Kenneth A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
2:52 PM
Arcutis Biotherapeutics (Issuer)
OSBORNE DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
2:51 PM
Arcutis Biotherapeutics (Issuer)
Turney Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:50 PM
Arcutis Biotherapeutics (Issuer)
OSBORNE DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:49 PM
Arcutis Biotherapeutics (Issuer)
Turney Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:48 PM
Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:47 PM
Arcutis Biotherapeutics (Issuer)
Lock Kenneth A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:45 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
2:33 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
7:35 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
6:29 PM
Arcutis Biotherapeutics (Issuer)
OSBORNE DAVID W (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/16/2021
5:32 PM
Arcutis Biotherapeutics (Issuer)
Lock Kenneth A. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/16/2021
5:31 PM
Arcutis Biotherapeutics (Issuer)
Turney Patricia A. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/16/2021
3:18 PM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
4:32 PM
Arcutis Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
10:14 AM
Arcutis Biotherapeutics (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
Form SC 13D/A
02/08/2021
8:54 PM
Arcutis Biotherapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
02/08/2021
4:00 PM
Arcutis Biotherapeutics (Subject)
Bain Capital Life Sciences Fund, L.P. (Filed by)
Form SC 13D/A
02/08/2021
12:45 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
9:15 AM
Arcutis Biotherapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/04/2021
3:37 PM
Arcutis Biotherapeutics (Filer)
Form 424B5
02/03/2021
10:24 AM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
10:23 AM
Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
6:39 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
7:30 AM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2021
7:07 PM
Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2021
3:41 PM
Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2021
12:14 PM
Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2021
10:11 AM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
2:13 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4/A
01/07/2021
1:39 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
12:16 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
2:15 PM
Arcutis Biotherapeutics (Issuer)
OSBORNE DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
2:14 PM
Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
2:14 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
6:40 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2020
4:08 PM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2020
10:57 AM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
4:31 PM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
3:34 PM
Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
3:33 PM
Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/04/2020
3:33 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2020
1:03 PM
Arcutis Biotherapeutics (Issuer)
Lock Kenneth A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
12:27 PM
Arcutis Biotherapeutics (Issuer)
Lock Kenneth A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
1:06 PM
Arcutis Biotherapeutics (Issuer)
Lock Kenneth A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
1:06 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2020
4:08 PM
Arcutis Biotherapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
10/06/2020
4:27 PM
Arcutis Biotherapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:23 PM
Arcutis Biotherapeutics (Issuer)
SILVERSTEIN JONATHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:52 PM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2020
1:42 PM
Arcutis Biotherapeutics (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
Form SC 13D/A
10/05/2020
8:13 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
8:12 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4/A
10/05/2020
3:16 PM
Arcutis Biotherapeutics (Filer)
Form 424B4
10/01/2020
11:15 PM
Arcutis Biotherapeutics (Filer)
Form EFFECT
10/01/2020
8:02 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
8:01 PM
Arcutis Biotherapeutics (Issuer)
OSBORNE DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
8:00 PM
Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:19 PM
Arcutis Biotherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.